GLUESEEKER Trademark

Trademark Overview


On Monday, October 14, 2024, a trademark application was filed for GLUESEEKER with the United States Patent and Trademark Office. The USPTO has given the GLUESEEKER trademark a serial number of 79413566. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, June 27, 2025. This trademark is owned by Phoremost Limited. The GLUESEEKER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for medical purposes; scientific and pharmaceutical research services; providing medical and scientific research information and advice relating to alleviation, diagnosis, prevention and treatment of disease and medical conditions; research and development services to find and develop new pharmaceutical products for others to put on the market; research into cancer and cancer prevention; providing phenotypic screening, namely, screenings that feature technology that enables targeted screening for systematic identification and access to intracellular druggable sites for scientific and pharmaceutical research and drug discovery purposes; information, advisory and consultancy services in relation to the aforesaid services.
glueseeker

General Information


Serial Number79413566
Word MarkGLUESEEKER
Filing DateMonday, October 14, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, June 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkGLUE SEEKER
Goods and ServicesScientific research for medical purposes; scientific and pharmaceutical research services; providing medical and scientific research information and advice relating to alleviation, diagnosis, prevention and treatment of disease and medical conditions; research and development services to find and develop new pharmaceutical products for others to put on the market; research into cancer and cancer prevention; providing phenotypic screening, namely, screenings that feature technology that enables targeted screening for systematic identification and access to intracellular druggable sites for scientific and pharmaceutical research and drug discovery purposes; information, advisory and consultancy services in relation to the aforesaid services.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhoremost Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, January 2, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 23, 2025ASSIGNED TO EXAMINER
Wednesday, April 2, 2025NON-FINAL ACTION WRITTEN
Thursday, April 3, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 7, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 7, 2025REFUSAL PROCESSED BY MPU
Friday, January 3, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, June 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 18, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 18, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 27, 2025REFUSAL PROCESSED BY IB
Friday, June 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED